Jason Industries, Inc. Reports Fourth Quarter and Full-Year 2015 Results
Mar 01, 2016 13:00 pm UTC| Business
Fourth quarter organic sales growth of three percentAnnounces cost reduction and margin expansion programProvides 2016 guidance MILWAUKEE, March 01, 2016 -- Jason Industries, Inc. (NASDAQ:JASN) (NASDAQ:JASNW) (“Jason”...
Camp Bow Wow® Launches Digital Campaign on iAPPS
Mar 01, 2016 13:00 pm UTC| Business
BURLINGTON, Mass., March 01, 2016 -- Bridgeline Digital, Inc. (NASDAQ:BLIN), The Digital Engagement Company™, announced today that Camp Bow Wow®, the Premier Doggy Day and Overnight Camp® franchise and an Entrepreneur...
Synaptics, BYD Automotive Partner on Innovative Vehicle Touchscreen Solutions
Mar 01, 2016 13:00 pm UTC| Business
SAN JOSE, Calif., March 01, 2016 -- Synaptics Incorporated (NASDAQ:SYNA), the leading developer of human interface solutions, today announced that BYD Automotive, one of China’s largest companies, has selected...
Motorcar Parts of America to Present at 28th Annual Roth Conference
Mar 01, 2016 13:00 pm UTC| Business
LOS ANGELES, March 01, 2016 -- Motorcar Parts of America, Inc. (Nasdaq:MPAA) today announced it is scheduled to make a presentation on Tuesday, March 15, 2016, at 9:30 a.m. Pacific time at the 28th Annual Roth...
Mar 01, 2016 13:00 pm UTC| Business
BERKELEY HEIGHTS, N.J., March 01, 2016 -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical stage biotechnology company developing novel hospital-based therapies in the management of acute, life-threatening conditions,...
Mar 01, 2016 13:00 pm UTC| Business
DUBLIN, Ireland, March 01, 2016 -- SIGMOID PHARMA LIMITED, a privately-owned, specialty pharmaceutical company developing innovative therapeutics for gastrointestinal and immunological diseases using its proprietary...
REGENXBIO Announces Appointment of Faraz Ali as Chief Business Officer
Mar 01, 2016 13:00 pm UTC| Business
ROCKVILLE, Md., March 01, 2016 -- REGENXBIO Inc.(Nasdaq:RGNX), a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno-associated virus (AAV) gene therapy based...